| __timestamp | Agios Pharmaceuticals, Inc. | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 22622695 |
| Thursday, January 1, 2015 | 141827000 | 24863028 |
| Friday, January 1, 2016 | 220163000 | 21351001 |
| Sunday, January 1, 2017 | 292681000 | 53837297 |
| Monday, January 1, 2018 | 1397000 | 16080096 |
| Tuesday, January 1, 2019 | 1317000 | 18525736 |
| Wednesday, January 1, 2020 | 2805000 | 2024000 |
| Friday, January 1, 2021 | 18777000 | 2548000 |
| Saturday, January 1, 2022 | 1704000 | 61556000 |
| Sunday, January 1, 2023 | 9504000 | 188157000 |
| Monday, January 1, 2024 | 4165000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Telix Pharmaceuticals Limited and Agios Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Agios Pharmaceuticals experienced a significant fluctuation, with a peak in 2017, where costs surged by over 190% compared to 2014. However, a dramatic reduction followed, with costs plummeting by 99% in 2018. In contrast, Telix Pharmaceuticals demonstrated a more consistent growth trajectory, with a notable 730% increase in 2023 compared to 2014. This suggests a strategic focus on scaling operations efficiently. The data highlights the contrasting approaches of these companies, with Agios showing volatility and Telix displaying steady growth. Such insights are invaluable for investors and industry analysts seeking to understand the dynamics of cost management in the pharmaceutical sector.
Cost of Revenue Trends: Pfizer Inc. vs Agios Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Zoetis Inc. and Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Cytokinetics, Incorporated vs Agios Pharmaceuticals, Inc.
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Amneal Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Ionis Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Comparison: Telix Pharmaceuticals Limited vs Xenon Pharmaceuticals Inc.
Analyzing Cost of Revenue: Telix Pharmaceuticals Limited and Vericel Corporation
Cost of Revenue: Key Insights for Telix Pharmaceuticals Limited and Wave Life Sciences Ltd.
Analyzing Cost of Revenue: Perrigo Company plc and Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Agios Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Cost of Revenue: Key Insights for Agios Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.